Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Krum

Showing results (11-20 of 421) with videos related to

Pageof 43
Sort By:
The American Journal of Cardiology|May 18, 2004
Tolerability of carvedilol in heart failure: clinical trials experienceHenry Krum
European Heart Journal|October 6, 2005
The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005)Henry Krum
European Heart Journal|October 15, 2013
Current clinical trials of cell-based therapies in cardiac repair: too many variables spoil the stem cell brothHenry Krum
Lancet (London, England)|November 20, 2009
Optimising management of chronic heart failureHenry Krum
Heart, Lung & Circulation|July 12, 2014
Statins in CHFHenry Krum, Ingrid Hopper
The Medical Journal of Australia|February 24, 2006
Chronic heart failure: time to recognize this major public health problemHenry Krum, Simon Stewart
International Journal of Clinical Practice|January 18, 2006
'Class effect' amongst cardiac drugs: term of convenience or pharmacological reality?Henry Krum, Frank Ruschitzka
Drug Safety|December 24, 2002
Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?Jennifer Martin, Henry Krum
Australian Family Physician|March 22, 2003
Recent advances in the management of chronic heart failureHenry Krum, Danny Liew
Journal of Cardiac Failure|June 10, 2006
Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard?Henry Krum, Peter Cameron
Pageof 43

Showing results (11-20 of 421) with videos related to

Sort By:
Pageof 43
The American Journal of Cardiology|May 18, 2004
Tolerability of carvedilol in heart failure: clinical trials experienceHenry Krum
European Heart Journal|October 6, 2005
The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005)Henry Krum
European Heart Journal|October 15, 2013
Current clinical trials of cell-based therapies in cardiac repair: too many variables spoil the stem cell brothHenry Krum
Lancet (London, England)|November 20, 2009
Optimising management of chronic heart failureHenry Krum
Heart, Lung & Circulation|July 12, 2014
Statins in CHFHenry Krum, Ingrid Hopper
The Medical Journal of Australia|February 24, 2006
Chronic heart failure: time to recognize this major public health problemHenry Krum, Simon Stewart
International Journal of Clinical Practice|January 18, 2006
'Class effect' amongst cardiac drugs: term of convenience or pharmacological reality?Henry Krum, Frank Ruschitzka
Drug Safety|December 24, 2002
Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?Jennifer Martin, Henry Krum
Australian Family Physician|March 22, 2003
Recent advances in the management of chronic heart failureHenry Krum, Danny Liew
Journal of Cardiac Failure|June 10, 2006
Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard?Henry Krum, Peter Cameron
Pageof 43